June 4, 2020 / Clinical Trials,Webinars

WATCH: Capricor’s HOPE-2 Final 12-Month Data – Webinar Recording

Capricor Therapeutics recently announced positive final 12-month results from the HOPE-2 Trial. HOPE-2 was a randomized, double-blind, placebo-controlled study focused on later-stage Duchenne patients. On June 3, 2020, Capricor joined PPMD for a webinar to discuss Capricor’s HOPE-2 clinical program.

If you missed the live event, the recording can be found below.


Watch the Recording


Join Our Mailing List